Ameritas Investment Partners’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Ameritas Investment Partners’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,020	Closed	-$61K	–	3366
2021 Q1	$61K	Buy	1,020 +383	+60%	+$13.9K	﹤0.01%	1973
2020 Q4	$9K	Hold	637	–	–	﹤0.01%	2862
2020 Q3	$7K	Buy	+637	New	+$10.9K	﹤0.01%	2903

Ameritas Investment Partners's PAND Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 1,020 shares — an estimated $61K sold.

Ameritas Investment Partners first reported a position in PAND in Q3 2020 and held it in 3 quarters. The position peaked at $61K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Ameritas Investment Partners reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Partners sold 1,020 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $61K.
Ameritas Investment Partners first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 3 quarters.
Ameritas Investment Partners's Pandion Therapeutics Inc. Common Stock position peaked at $61K in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.